title: Thrombocytopenia with rituximab treatment--splenomegaly as the risk factor.
authors.forename: Jagdish
authors.initials: J
authors.lastname: Adiyodi
authors.forename: Jecko
authors.initials: J
authors.lastname: Thachil
authors.forename: Stephen
authors.initials: S
authors.lastname: Hawkins
authors.forename: Ian
authors.initials: I
authors.lastname: Hincks
authors.forename: Barrie E
authors.initials: BE
authors.lastname: Woodcock
authors.forename: Rahuman
authors.initials: R
authors.lastname: Salim
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D012307:Risk Factors; D000069283:Rituximab; D013163:Splenomegaly / Q000139:chemically induced* / Q000175:diagnosis*; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000175:diagnosis*; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab